Science & Tech

After COVID vaccines, time to use mRNA tech against other infectious diseases

After COVID Vaccines, Time to Use mRNA Tech Against Other Infectious Diseases | GZERO Media

Using mRNA technology to develop effective COVID vaccines has been a scientific breakthrough.

But that's just the tip of the iceberg, Melanie Saville, head of vaccine development at the Coalition for Epidemic Preparedness Innovations, said during a livestream discussion on equitable vaccine distribution hosted by GZERO Media in partnership with the Bill & Melinda Gates Foundation. "

There's still a lot that should be done with the technology moving forward" on other infectious diseases like HIV, malaria, or TB. Still, she said that vaccines are only the beginning.

Local manufacturing and distribution is as important — as is future equitable access to the mRNA tech itself.

More For You

Mock up display at Paris Air Show of the FCAS aircraft, the Future Combat Air System a Next-Generation Weapon System NGWS and a New Generation Fighter NGF planned as a sixth-generation jet fighter in development from Dassault aviation, Airbus and Indra Sistemas in partnership and support of the French, German and Spanish Air Force.
Nicolas Economou/NurPhoto

France and Germany have scrapped their $115.6 billion joint fighter jet project, collapsing Europe's most ambitious defense initiative after years of corporate infighting.

US President Donald Trump and Canada's Prime Minister Mark Carney meet in the Oval Office at the White House in Washington, D.C., USA, on October 7, 2025.
REUTERS/Evelyn Hockstein/File Photo

The US-Canada relationship has long been one of the closest partnerships in the world, but tensions have emerged since Donald Trump returned to office. The timing is far from ideal: the USMCA trade agreement is up for review in a few weeks.